FDA Hits Drug Repackager With Mislabeling Suit

Law360, New York (June 20, 2013, 5:30 PM EDT) -- The U.S. Food and Drug Administration on Thursday sued a drug repackaging company in Ohio federal court, alleging it had continually failed to fix processing problems highlighted in prior warnings by the regulator, resulting in the distribution of adulterated and mislabeled drugs.

According to the FDA, Shamrock Medical Solutions Group LLC had violated the Food, Drug and Cosmetic Act by failing to correct repeated deficiencies with its drug repackaging process, paying lip service to the need for corrections while continuing to distribute potentially dangerous mislabeled and...
To view the full article, register now.




Case Information

Case Title

United States of America v. Shamrock Medical Solutions Group, LLC et al

Case Number



Ohio Southern

Nature of Suit

Agriculture Acts


Algenon L. Marbley

Date Filed

June 20, 2013

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.